Legal Opinion
Kaiser Foundation Health Plan, Inc. v. Pfizer, Inc.
Court of Appeals for the First Circuit
Decided April 3, 2013No. 11-1904, 11-2096PublishedCited by 60 opinions
1Opinion of the Court
LYNCH, Chief Judge.
This is an appeal from verdicts of over $140 million, reached by both a jury and a court, compensating Kaiser, a major health plan provider and insurer, for the injury Kaiser suffered by its payment for four categories of off-label Neurontin prescriptions which had been induced by a fraudulent scheme by Pfizer, the manufacturer of Neurontin. These verdicts followed a settlement that Warner-Lambert, a subdivision of Pfizer, had reached in a criminal case brought by the United States, in which Warner-Lambert pled guilty to two counts and agreed to pay a $240 million criminal…
2Cases cited40 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Associated General Contractors of California, Inc. v. California State Council of CarpentersSupreme Court of the United States · 1983
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
- Duren v. MissouriSupreme Court of the United States · 1979
- Amgen Inc. v. Connecticut Retirement Plans and Trust FundsSupreme Court of the United States · 2013
35 more not listed; retrieve them via the Exa API.
3Cited by60 opinions
- United States Ex Rel. Booker v. Pfizer, Inc.Court of Appeals for the First Circuit · 2017
- In Re Avandia Marketing, Sales Practices & Product Liability LitigationCourt of Appeals for the Third Circuit · 2015
- Painters & Allied Trades Dist. Council 82 Health Care Fund v. Forest Pharm., Inc. (In Re Celexa & Lexapro Mktg. & Sales Practices Litig.)Court of Appeals for the First Circuit · 2019
- Pat District Council 82 v. Takeda Pharmaceuticals CompanyCourt of Appeals for the Ninth Circuit · 2019
- Sergeants Benevolent Ass'n Health & Welfare Fund v. LouisianaCourt of Appeals for the Second Circuit · 2015
55 more not listed; retrieve them via the Exa API.